DermAb.io
PrivateLast Round
Accelerator
Mar 15, 2025
Company Overview
DermAb.io operates in Healthcare & Life Sciences and is based in Haifa. Its latest recorded funding round was an Accelerator round in March 2025.
DermAb.io is a healthtech company that develops a non-invasive skin biomarker platform to provide clinical decision support for personalized biologic therapy selection in chronic and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DermAb.io Comparables
Compare DermAb.io with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mindera Health | 87% | |
| AMPEL BioSolutions | 78% | |
| FibroTx | 77% |
For institutional investors. Book with your work email.
DermAb.io Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 15, 2025 | ||||
| Accelerator | Mar 6, 2024 | ||||
| Accelerator | Nov 9, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DermAb.io Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MindUP | Accelerator |
| Israel Innovation Authority | Accelerator |
| AlphaLab | Accelerator |
| Innovation Works | Accelerator |
| MassChallenge Israel | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 15, 2025
Funding round included Innovation Works and AlphaLab.
- Mar 6, 2024
Received funding from MassChallenge Israel.
For institutional investors. Book with your work email.
DermAb.io Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DermAb.io's valuation, stock price, and market status.
Is DermAb.io a public or private company?
DermAb.io is a private company.
What is the current stock price of DermAb.io?
DermAb.io is a private company, so its shares have no public market price. Caplight tracks DermAb.io's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DermAb.io worth (valuation)?
Valuation information for DermAb.io is not publicly available.
Can I buy DermAb.io stock?
DermAb.io shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DermAb.io's last funding round?
DermAb.io's most recent funding round was Accelerator on March 15, 2025.
Who are the main investors in DermAb.io?
Key investors in DermAb.io include MindUP.
Will DermAb.io IPO soon?
No public IPO plans have been announced for DermAb.io.
How can I track DermAb.io secondary market activity?
Caplight tracks bids, offers, and trades in DermAb.io's shares on secondary markets.